https://www.selleckchem.com/pr....oducts/pixantrone-ma
s a reliable monitor to assess nociception in a population of patients under chronic beta-blocker therapy. Patients under such therapy achieve similar maximal NOL values over a 180 s period after a standardized noxious stimulus and the NOL variation over time, represented by the AUC is not significantly different from a cohort of non-beta-blocked patients. Whether the patient takes beta-blockers or not, sensitivity of the NOL index is greater than that seen for BIS index or heart rate to detect an experimental noxious stimulu
Like
Comment
Share
Victoria Wilburn
https://www.devex.com/people/c....an-i-get-a-refund-fr
https://www.devex.com/people/c....an-i-get-a-refund-fr
https://www.devex.com/people/a....re-expedia-trips-ful
Delete Comment
Are you sure that you want to delete this comment ?